Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Current Medical Research and Opinion|June 23, 2005
The cognitive effects of cholinesterase inhibitor treatment in every-day practiceE Kapaki, G P ParaskevasBiological Trace Element Research|February 1, 1997
Trace elements, age, and sex in amyotrophic lateral sclerosis diseaseG D Kanias, E KapakiActa Neurologica Scandinavica|May 1, 1989
Zinc, copper and magnesium concentration in serum and CSF of patients with neurological disordersE Kapaki, J Segditsa, C PapageorgiouEuropean Neurology|June 1, 2000
Increased cerebrospinal fluid tau protein in multiple sclerosisE Kapaki, G P Paraskevas, M Michalopoulou, et al.European Journal of Neurology|February 27, 2003
CSF tau protein and beta-amyloid (1-42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek populationE Kapaki, G P Paraskevas, I Zalonis, et al.Experientia|December 1, 1989
Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseasesE Kapaki, J Segditsa, C Zournas, et al.Prenatal Diagnosis|March 1, 1996
Prenatal diagnosis of X-linked spinal and bulbar muscular atrophy in a Greek familyC Yapijakis, E Kapaki, M Boussiou, et al.International Angiology : a Journal of the International Union of Angiology|December 1, 1995
Raeder's syndrome. Report of two casesC Zournas, E Kapaki, S Doris, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 21, 2001
Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease?E Kapaki, K Kilidireas, G P Paraskevas, et al.Acta Neurologica Scandinavica|March 1, 1991
Neuropathy following acute intoxication with Mecarbam (OP ester)E Stamboulis, A Psimaras, D Vassilopoulos, et al.Pageof 3